SirTlab Corporation

Pioneering biotechnology company developing innovative therapies based on increasing SIRT6 protein activity to improve human health and extend lifespan.

Health Tech & Life Sciences
Active
Seed Ramat Gan, Israel Founded 2012
Website ↗
Last updated 2026-07-26
Total raised
$889K
Last: Undisclosed Round 2025-05
Stage
Seed
Founded
2012
Headcount
6
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

SirTlab Corporation is a pioneering biotechnology company committed to advancing the frontiers of science to create innovative therapies based on increasing the activity of SIRT6 protein to improve human health and extend life span. The company's drugs are focused on the high-level expression of sirtuin, a key orchestrator of responses to lipids, glucose, and inflammation that suppresses triglyceride synthesis, fat metabolism, and inflammation as well as glycolysis with improved liver function tests and reversed fatty liver progression. SirTlab aims to treat age-related diseases such as fatty liver disease, frailty, inflammatory diseases, neurodegeneration, and osteoporosis, with the ultimate goal of extending healthy human lifespan.

Funding history · 3 rounds · $889K total

2025-04
Undisclosed Round Undisclosed
★ PipelBiz
2021-11
Undisclosed Round Undisclosed
2021-11
Grant $889K

Q&A

What is SirTlab Corporation's primary focus?
SirTlab Corporation is a biotechnology company focused on developing therapies that increase SIRT6 protein activity to improve human health and extend lifespan, particularly for age-related diseases such as fatty liver disease, frailty, inflammatory diseases, neurodegeneration, and osteoporosis.
When was SirTlab Corporation founded?
SirTlab Corporation was founded in January 2012.
What is the employee count for SirTlab Corporation?
SirTlab Corporation has 1-10 employees.
What is the total amount of funding SirTlab Corporation has raised to date?
SirTlab Corporation has raised a total of $1,530,208 USD.
What type of funding did SirTlab Corporation secure in November 2022?
In November 2022, SirTlab Corporation secured a Seed round of equity funding totaling $485,760 USD.
Who are the co-founders of SirTlab Corporation?
The co-founders of SirTlab Corporation are Boaz Misholi, who serves as CEO & Chairman, and Haim Cohen, who is a Director and CSO.
What is SirTlab Corporation's primary sector?
SirTlab Corporation's primary sector is Health Tech & Life Sciences.

Team · 2

Boaz Misholi
Founder · Co-founder, CEO & Chairman
Haim Cohen
Founder · Co-founder, Director, CSO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Highlights

1 Patents

Tags

anti-agingtherapeuticspharmaceuticalsgeneticspharma-companieschronic-patients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)